Skip to main content

Advertisement

Open Peer Review Reports for: DocOx (AIO-PK0106): a phase II trial of docetaxel and oxaliplatin as a second line systemic therapy in patients with advanced pancreatic ductal adenocarcinoma

Back to article

Pre-publication versions of this article are available by contacting info@biomedcentral.com.

Original Submission
28 Jul 2015 Submitted Original manuscript
4 Sep 2015 Reviewed Reviewer Report - Lanjing Zhang
23 Sep 2015 Reviewed Reviewer Report - JIN LI
1 Oct 2015 Reviewed Reviewer Report - Motoyoshi Tanaka
31 Oct 2015 Author responded Author comments - Thomas Ettrich
Resubmission - Version 2
31 Oct 2015 Submitted Manuscript version 2
1 Dec 2015 Author responded Author comments - Thomas Ettrich
Resubmission - Version 3
1 Dec 2015 Submitted Manuscript version 3
14 Dec 2015 Author responded Author comments - Thomas Ettrich
Resubmission - Version 4
14 Dec 2015 Submitted Manuscript version 4
Publishing
6 Jan 2016 Editorially accepted
15 Jan 2016 Article published 10.1186/s12885-016-2052-4

How does Open Peer Review work?

Open peer review is a system where authors know who the reviewers are, and the reviewers know who the authors are. If the manuscript is accepted, the named reviewer reports are published alongside the article. Pre-publication versions of the article are available by contacting info@biomedcentral.com.

You can find further information about the peer review system here.

Advertisement